• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
VBS

VECTUS BIOSYSTEMS LIMITED

1.79% ! 28.5¢
Market Cap $14.93M  !

Vectus Biosystems Limited is an Australia-based drug discovery and development company.... Vectus Biosystems Limited is an Australia-based drug discovery and development company. The Company focuses on medical research and development. It is engaged in developing a treatment for fibrosis and high blood pressure, which includes the treatment for diseases in the fibrotic market, namely heart, kidney, and liver diseases. Its compound, VB0004, focuses on treating the hardening of functional tissue and high blood pressure. It also focuses on developing candidates for the treatment of fibrotic liver diseases, including non-alcoholic steatohepatitis (NASH) as well as pulmonary fibrotic diseases. The Company has also developed technology focused at improving the speed and accuracy of measuring the amount of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) in samples tested in laboratories. Accugen is a platform, developed by its wholly owned subsidiary, Accugen Pty Limited, comprising of reagents, and software that quantitate polymerase chain reaction (qPCR) reactions.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
VBS 11/11/25 0 223
11/11/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  223 
VBS 07/11/25 2 1.1K
07/11/25 Last post  Stellarbot Comments Created with Sketch.  2  Views Created with Sketch.  1.1K 
VBS 30/10/25 0 200
Metals & Mining SECTOR NEWS

This stock just expanded its US critical minerals footprint

TMG
14 Nov 2025
TRIGG MINERALS LIMITED
30/10/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  200 
VBS 24/10/25 0 117
24/10/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  117 
VBS 17/10/25 0 150
17/10/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  150 
VBS 17/10/25 0 124
17/10/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  124 
VBS 16/10/25 4 763
16/10/25 Last post  MoneyGrinch Comments Created with Sketch.  4  Views Created with Sketch.  763 
VBS 15/10/25 0 72
15/10/25 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  72 

See All Discussions arrow Created with Sketch.

Timeline

Response to ASX Query Letter
11 Nov 15:51
 
Quarterly Activities & Appendix 4C Cash Flow Reports
30 Oct 18:28
 
Notice of 2025 Annual General Meeting & Proxy Form
24 Oct 16:14
 
Reinstatement to Quotation
17 Oct 18:37
 
VB4-P5 Renal Compound Transaction
17 Oct 18:37
 
Suspension from Quotation
17 Oct 12:12
 
View More arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
28.5¢
Change
0.005(1.79%)
Mkt cap ! $14.93M
Open High Low Value Volume
28.5¢ 28.5¢ 28.5¢ $499 1.75K

Buyers (Bids)

No. Vol. Price($)
1 2000 26.5¢
 

Sellers (Offers)

Price($) Vol. No.
28.0¢ 16336 1
View Market Depth
Last trade - 09.59am 14/11/2025 (20 minute delay) ?
Last
27.5¢
  Change
0.005 ( 1.79 %)
Open High Low Volume
27.5¢ 27.5¢ 27.5¢ 997
Last updated 10.20am 14/11/2025 ?
VBS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.